Diabetes mellitus is a chronic disease with high a health impact and that affects an increasing number of citizens. This is further stressed by the fact that this year the World Health Organisation, WHO, has included diabetes mellitus among the top 10 causes of death. It is worth noting that the most common diabetes is type 2 diabetes mellitus, which accounts for over 90% of all cases. In Spain, according to the latest national study, this disease has a prevalence up to 13.8%, despite the fact that only about half the people who suffer from it have been diagnosed.
DADDi2 is a coordinated project, led by the National Microelectronics Centre, IMB-CNM (CSIC), and in collaboration with the University of Barcelona (UB), and endocrinologists from the Germans Trias i Pujol Hospital (HGTP) located in Badalona.
The project goal is to develop a disposable device for the early diagnosis of diabetes mellitus. Such a device will be energetically autonomous and entirely disposable, and it will be able to determine the blood concentration of glucose, total cholesterol, and triglyceryds. The device will be compact, it will be highly integrated, and will be fabricated using low-cost materials and technologies as far as possible with a view to its eventual industrialization.
DADDi2 aims at developing a demonstrator able to determine the blood concentration of glucose, total cholesterol and triglycerydes. The device will be able to perform such multianalyte measurements autonomously (from the energy viewpoint), and with a minimum user intervention. In addition to the clinical value of this new tool, the concept of energy autonomy and systems integration developed in this project will spark a new generation of rapid and portable detection devices of use other areas such as sports, environment, or drug abuse detection.
DADDi2 is funded by the Spanish Ministry of Economy (MINECO) under reference TEC2013-48506-C3-1-R.
Project duration: 01-01-2014 to 31-12-2016.Contact me
to find out more about the project.